Global Merkel Cell Carcinoma Treatment Market Professional Survey Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Merkel Cell Carcinoma Treatment Revenue
• 1.4 Market by Type
  • 1.4.1 Global Merkel Cell Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Chemotherapy
  • 1.4.3 Immunotherapy
  • 1.4.4 Combination Therapies
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Merkel Cell Carcinoma Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Ambulatory Surgical Centres
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Merkel Cell Carcinoma Treatment Market Perspective (2015-2026)
• 2.2 Global Merkel Cell Carcinoma Treatment Growth Trends by Regions
  • 2.2.1 Merkel Cell Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Merkel Cell Carcinoma Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Merkel Cell Carcinoma Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Merkel Cell Carcinoma Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Merkel Cell Carcinoma Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Merkel Cell Carcinoma Treatment Players by Market Size
  • 3.1.1 Global Top Merkel Cell Carcinoma Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Merkel Cell Carcinoma Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Merkel Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Merkel Cell Carcinoma Treatment Market Concentration Ratio
  • 3.2.1 Global Merkel Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Merkel Cell Carcinoma Treatment Revenue in 2019
• 3.3 Merkel Cell Carcinoma Treatment Key Players Head office and Area Served
• 3.4 Key Players Merkel Cell Carcinoma Treatment Product Solution and Service
• 3.5 Date of Enter into Merkel Cell Carcinoma Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Merkel Cell Carcinoma Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)
• 5.2 Global Merkel Cell Carcinoma Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 6.2 Merkel Cell Carcinoma Treatment Key Players in North America (2019-2020)
• 6.3 North America Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 6.4 North America Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 7.2 Merkel Cell Carcinoma Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 7.4 Europe Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 8.2 Merkel Cell Carcinoma Treatment Key Players in China (2019-2020)
• 8.3 China Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 8.4 China Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 9.2 Merkel Cell Carcinoma Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 9.4 Japan Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 10.2 Merkel Cell Carcinoma Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 11.2 Merkel Cell Carcinoma Treatment Key Players in India (2019-2020)
• 11.3 India Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 11.4 India Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Merkel Cell Carcinoma Treatment Market Size (2015-2020)
• 12.2 Merkel Cell Carcinoma Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Merkel Cell Carcinoma Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Merkel Cell Carcinoma Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Merck
  • 13.1.1 Merck Company Details
  • 13.1.2 Merck Business Overview
  • 13.1.3 Merck Merkel Cell Carcinoma Treatment Introduction
  • 13.1.4 Merck Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020))
  • 13.1.5 Merck Recent Development
• 13.2 Amgen Inc
  • 13.2.1 Amgen Inc Company Details
  • 13.2.2 Amgen Inc Business Overview
  • 13.2.3 Amgen Inc Merkel Cell Carcinoma Treatment Introduction
  • 13.2.4 Amgen Inc Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.2.5 Amgen Inc Recent Development
• 13.3 Apcure SAS
  • 13.3.1 Apcure SAS Company Details
  • 13.3.2 Apcure SAS Business Overview
  • 13.3.3 Apcure SAS Merkel Cell Carcinoma Treatment Introduction
  • 13.3.4 Apcure SAS Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.3.5 Apcure SAS Recent Development
• 13.4 BeiGene Ltd
  • 13.4.1 BeiGene Ltd Company Details
  • 13.4.2 BeiGene Ltd Business Overview
  • 13.4.3 BeiGene Ltd Merkel Cell Carcinoma Treatment Introduction
  • 13.4.4 BeiGene Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.4.5 BeiGene Ltd Recent Development
• 13.5 Immune Design Corp
  • 13.5.1 Immune Design Corp Company Details
  • 13.5.2 Immune Design Corp Business Overview
  • 13.5.3 Immune Design Corp Merkel Cell Carcinoma Treatment Introduction
  • 13.5.4 Immune Design Corp Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.5.5 Immune Design Corp Recent Development
• 13.6 Merck & Co Inc
  • 13.6.1 Merck & Co Inc Company Details
  • 13.6.2 Merck & Co Inc Business Overview
  • 13.6.3 Merck & Co Inc Merkel Cell Carcinoma Treatment Introduction
  • 13.6.4 Merck & Co Inc Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.6.5 Merck & Co Inc Recent Development
• 13.7 Merck KGaA
  • 13.7.1 Merck KGaA Company Details
  • 13.7.2 Merck KGaA Business Overview
  • 13.7.3 Merck KGaA Merkel Cell Carcinoma Treatment Introduction
  • 13.7.4 Merck KGaA Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.7.5 Merck KGaA Recent Development
• 13.8 Millennium Pharmaceuticals Inc
  • 13.8.1 Millennium Pharmaceuticals Inc Company Details
  • 13.8.2 Millennium Pharmaceuticals Inc Business Overview
  • 13.8.3 Millennium Pharmaceuticals Inc Merkel Cell Carcinoma Treatment Introduction
  • 13.8.4 Millennium Pharmaceuticals Inc Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.8.5 Millennium Pharmaceuticals Inc Recent Development
• 13.9 NantKwest Inc
  • 13.9.1 NantKwest Inc Company Details
  • 13.9.2 NantKwest Inc Business Overview
  • 13.9.3 NantKwest Inc Merkel Cell Carcinoma Treatment Introduction
  • 13.9.4 NantKwest Inc Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.9.5 NantKwest Inc Recent Development
• 13.10 Novartis AG
  • 13.10.1 Novartis AG Company Details
  • 13.10.2 Novartis AG Business Overview
  • 13.10.3 Novartis AG Merkel Cell Carcinoma Treatment Introduction
  • 13.10.4 Novartis AG Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 13.10.5 Novartis AG Recent Development
• 13.11 OncoSec Medical Inc
  • 10.11.1 OncoSec Medical Inc Company Details
  • 10.11.2 OncoSec Medical Inc Business Overview
  • 10.11.3 OncoSec Medical Inc Merkel Cell Carcinoma Treatment Introduction
  • 10.11.4 OncoSec Medical Inc Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 10.11.5 OncoSec Medical Inc Recent Development
• 13.12 Oncovir Inc
  • 10.12.1 Oncovir Inc Company Details
  • 10.12.2 Oncovir Inc Business Overview
  • 10.12.3 Oncovir Inc Merkel Cell Carcinoma Treatment Introduction
  • 10.12.4 Oncovir Inc Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 10.12.5 Oncovir Inc Recent Development
• 13.13 Ono Pharmaceutical Co Ltd
  • 10.13.1 Ono Pharmaceutical Co Ltd Company Details
  • 10.13.2 Ono Pharmaceutical Co Ltd Business Overview
  • 10.13.3 Ono Pharmaceutical Co Ltd Merkel Cell Carcinoma Treatment Introduction
  • 10.13.4 Ono Pharmaceutical Co Ltd Revenue in Merkel Cell Carcinoma Treatment Business (2015-2020)
  • 10.13.5 Ono Pharmaceutical Co Ltd Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer